XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q1)Dec 28, 2024 | (FY)Sep 28, 2024 | (Q4)Sep 28, 2024 | (Q3)Jun 29, 2024 | (Q2)Mar 30, 2024 | (Q1)Dec 30, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jul 1, 2023 | (Q2)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.85%24.69B | 2.77%91.36B | 6.28%22.57B | 3.69%23.16B | 1.23%22.08B | 0.16%23.55B | 7.47%88.9B | 5.41%21.24B | 3.84%22.33B | 21.82B |
Operating revenue | 4.85%24.69B | 2.77%91.36B | 6.28%22.57B | 3.69%23.16B | 1.23%22.08B | 0.16%23.55B | 7.47%88.9B | 5.41%21.24B | 3.84%22.33B | --21.82B |
Cost of revenue | -1.16%15.41B | -0.85%58.7B | 3.66%14.23B | 1.64%14.71B | -3.04%14.17B | -4.88%15.59B | 8.82%59.2B | 1.25%13.73B | 5.77%14.47B | 14.62B |
Gross profit | 16.60%9.28B | 9.99%32.66B | 11.06%8.34B | 7.47%8.45B | 9.89%7.91B | 11.73%7.96B | 4.86%29.7B | 13.97%7.51B | 0.47%7.86B | 7.2B |
Operating expense | 3.58%5.21B | 0.21%20.75B | 3.11%5.6B | -2.41%5.09B | 2.19%5.03B | -2.08%5.03B | -3.93%20.71B | -10.25%5.43B | -3.19%5.22B | 4.92B |
Selling and administrative expenses | 3.89%3.93B | 2.76%15.76B | 7.29%4.31B | -0.05%3.87B | 4.87%3.79B | -1.15%3.78B | -6.42%15.34B | -15.04%4.02B | -5.51%3.87B | --3.61B |
Depreciation amortization depletion | 2.65%1.28B | -7.06%4.99B | -8.80%1.29B | -9.23%1.22B | -5.19%1.24B | -4.82%1.24B | 3.99%5.37B | 6.99%1.41B | 4.19%1.34B | --1.31B |
-Depreciation and amortization | 2.65%1.28B | -7.06%4.99B | -8.80%1.29B | -9.23%1.22B | -5.19%1.24B | -4.82%1.24B | 3.99%5.37B | 6.99%1.41B | 4.19%1.34B | --1.31B |
Operating profit | 38.90%4.08B | 32.50%11.91B | 31.78%2.75B | 27.00%3.35B | 26.55%2.88B | 47.32%2.94B | 32.82%8.99B | 284.32%2.08B | 8.59%2.64B | 2.28B |
Net non-operating interest income expense | -25.14%-433M | -4.22%-1.26B | -28.01%-361M | -12.13%-342M | 3.42%-311M | -15.33%-346M | 13.46%-1.21B | 13.50%-282M | 18.23%-305M | -322M |
Non-operating interest income | -70.33%54M | -4.25%406M | -92.56%-233M | -15.66%167M | 4.40%190M | 10.30%182M | 371.11%424M | -363.04%-121M | 2,728.57%198M | --182M |
Non-operating interest expense | -7.77%487M | 4.92%2.07B | 6.19%532M | 1.19%509M | -0.60%501M | 13.55%528M | 27.37%1.97B | 15.44%501M | 32.37%503M | --504M |
Total other finance cost | ---- | -18.82%-404M | ---- | ---- | ---- | ---- | -448.39%-340M | ---- | ---- | ---- |
Other net income (expense) | -94.66%15M | -2.36%-3.09B | -80.86%-1.44B | 103.28%81M | -1,224.12%-1.91B | 251.25%281M | -3,325.00%-3.01B | -596.25%-794M | -4,216.67%-2.47B | 170M |
Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | 125.49%169M | --0 | 166.18%90M | --149M |
Earnings from equity interest | -49.17%92M | -26.47%575M | -52.86%107M | -23.56%146M | -18.50%141M | -5.24%181M | -4.17%782M | 59.86%227M | -15.11%191M | --173M |
Special income (charges) | ---143M | 8.34%-3.66B | -37.52%-1.54B | 97.55%-65M | -1,250.00%-2.05B | --0 | -1,584.81%-3.99B | ---1.12B | -6,209.52%-2.65B | ---152M |
-Less:Restructuring and merger&acquisition | --143M | -7.63%3.6B | 51.13%1.54B | --0 | 1,250.00%2.05B | --0 | 1,542.19%3.89B | --1.02B | 6,209.52%2.65B | --152M |
-Less:Other special charges | ---- | -35.64%65M | --0 | --65M | ---- | ---- | --101M | ---- | ---- | ---- |
Other non- operating income (expenses) | -34.00%66M | ---- | ---- | ---- | ---- | 257.14%100M | 800.00%28M | 324.44%101M | -876.92%-101M | ---- |
Income before tax | 27.48%3.66B | 58.71%7.57B | -5.86%948M | 2,408.21%3.09B | -69.05%657M | 61.93%2.87B | -9.76%4.77B | 167.82%1.01B | -106.32%-134M | 2.12B |
Income tax | 41.11%1.02B | 30.24%1.8B | 22.68%384M | 1,221.05%251M | -30.55%441M | 74.76%720M | -20.38%1.38B | 156.56%313M | -96.92%19M | 635M |
Net income | 22.92%2.64B | 70.29%5.77B | -18.73%564M | 1,957.52%2.84B | -85.48%216M | 58.05%2.15B | -3.28%3.39B | 173.23%694M | -110.19%-153M | 1.49B |
Net income continuous Operations | 22.92%2.64B | 70.29%5.77B | -18.73%564M | 1,957.52%2.84B | -85.48%216M | 58.05%2.15B | -4.59%3.39B | 173.23%694M | -110.19%-153M | --1.49B |
Net income discontinuous operations | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Minority interest income | -62.50%90M | -22.68%801M | -75.81%104M | -28.01%221M | 8.76%236M | 192.68%240M | 187.78%1.04B | 367.39%430M | 230.11%307M | 217M |
Net income attributable to the parent company | 33.65%2.55B | 111.21%4.97B | 74.24%460M | 669.78%2.62B | -101.57%-20M | 49.41%1.91B | -25.15%2.35B | 62.96%264M | -132.65%-460M | 1.27B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 33.65%2.55B | 111.21%4.97B | 74.24%460M | 669.78%2.62B | -101.57%-20M | 49.41%1.91B | -25.15%2.35B | 62.96%264M | -132.65%-460M | 1.27B |
Basic earnings per share | 35.58%1.41 | 110.85%2.72 | 78.57%0.25 | 676.00%1.44 | -101.43%-0.01 | 48.57%1.04 | -25.43%1.29 | 55.56%0.14 | -132.47%-0.25 | 0.7 |
Diluted earnings per share | 34.62%1.4 | 110.85%2.72 | 78.57%0.25 | 672.00%1.43 | -101.45%-0.01 | 48.57%1.04 | -25.00%1.29 | 55.56%0.14 | -132.47%-0.25 | 0.69 |
Dividend per share | 66.67%0.5 | 0.75 | 0.45 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |